161 related articles for article (PubMed ID: 8215580)
21. Postnatal corticosteroids for preterm infants--do what we say, not what we do.
Jobe AH
N Engl J Med; 2004 Mar; 350(13):1349-51. PubMed ID: 15044647
[No Abstract] [Full Text] [Related]
22. Postnatal steroids for the treatment of bronchopulmonary dysplasia: a complex case presentation.
Forest S
J Perinat Neonatal Nurs; 2011; 25(3):283-91; quiz 292-3. PubMed ID: 21825919
[TBL] [Abstract][Full Text] [Related]
23. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia.
Lim G; Lee BS; Choi YS; Park HW; Chung ML; Choi HJ; Kim EA; Kim KS
Pediatr Neonatol; 2015 Aug; 56(4):261-7. PubMed ID: 25649722
[TBL] [Abstract][Full Text] [Related]
24. Minidex: very low dose dexamethasone (0.05 mg/kg/day) in chronic lung disease.
Yates HL; Newell SJ
Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F190-4. PubMed ID: 21115554
[TBL] [Abstract][Full Text] [Related]
25. Effect of dexamethasone on leukocyte numbers and lymphocyte-blastogenic responses to mitogens in infants with bronchopulmonary dysplasia.
Moya FR; Becerra M; Leiva L; Sorensen RU
Clin Pediatr (Phila); 1993 Mar; 32(3):185-8. PubMed ID: 8453841
[No Abstract] [Full Text] [Related]
26. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials.
Onland W; Offringa M; De Jaegere AP; van Kaam AH
Pediatrics; 2009 Jan; 123(1):367-77. PubMed ID: 19117904
[TBL] [Abstract][Full Text] [Related]
27. Dexamethasone in the treatment of bronchopulmonary dysplasia.
Benini F; Rubaltelli FF; Griffith P; Sala M; Zorzi C
Acta Paediatr Scand Suppl; 1989; 360():108-12. PubMed ID: 2642245
[TBL] [Abstract][Full Text] [Related]
28. Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia.
Williams AF; Jones M
Arch Dis Child; 1992 Jan; 67(1 Spec No):5-9. PubMed ID: 1536587
[TBL] [Abstract][Full Text] [Related]
29. Hypertrophy of the tongue associated with inhaled corticosteroid therapy in premature infants.
Linder N; Kuint J; German B; Lubin D; Loewenthal R
J Pediatr; 1995 Oct; 127(4):651-3. PubMed ID: 7562295
[TBL] [Abstract][Full Text] [Related]
30. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF
Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
[TBL] [Abstract][Full Text] [Related]
31. [Function of the hypothalamo-hypophyseal-adrenal axis to corticotropin-releasing hormone test in premature infants with bronchopulmonary dysplasia].
Merz U; Pfäffle R; Peschgens T; Hörnchen H
Z Geburtshilfe Neonatol; 1997; 201(6):253-7. PubMed ID: 9491545
[TBL] [Abstract][Full Text] [Related]
32. Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia.
Ohning BL; Fyfe DA; Riedel PA
Am Heart J; 1993 Jan; 125(1):253-6. PubMed ID: 8417533
[No Abstract] [Full Text] [Related]
33. Which course of dexamethasone?
Bloomfield FH; Knight DB; Harding JE
Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F80. PubMed ID: 10325825
[No Abstract] [Full Text] [Related]
34. Diabetic ketoacidosis after steroid administration for bronchopulmonary dysplasia: a case report.
Spear ML; Reeves G; Pearlman SA
J Perinatol; 1993; 13(3):232-4. PubMed ID: 8345389
[No Abstract] [Full Text] [Related]
35. Renal calcification after dexamethasone in infants with bronchopulmonary dysplasia.
Kamitsuka MD; Peloquin D
Lancet; 1991 Mar; 337(8741):626. PubMed ID: 1671989
[No Abstract] [Full Text] [Related]
36. Bronchopulmonary dysplasia: treatment success with dexamethasone.
Hearne AB
J Natl Med Assoc; 1982 Aug; 74(8):795-800. PubMed ID: 7131578
[TBL] [Abstract][Full Text] [Related]
37. Dexamethasone for preterm infants at risk of bronchopulmonary dysplasia: is timing everything?
Been JV; Simons SHP; Labrecque JA
Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37857434
[No Abstract] [Full Text] [Related]
38. L-selectin expression on polymorphonuclear leukocytes and monocytes in premature infants: reduced expression after dexamethasone treatment for bronchopulmonary dysplasia.
Waisman D; Van Eeden SF; Hogg JC; Solimano A; Massing B; Bondy GP
J Pediatr; 1998 Jan; 132(1):53-6. PubMed ID: 9470000
[TBL] [Abstract][Full Text] [Related]
39. Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review.
Doyle LW; Ehrenkranz RA; Halliday HL
Neonatology; 2010; 98(4):289-96. PubMed ID: 20453523
[TBL] [Abstract][Full Text] [Related]
40. On dexamethasone in bronchopulmonary dysplasia.
Frank L
Pediatr Pulmonol; 1994 Mar; 17(3):205-6. PubMed ID: 8197003
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
